| Hang Seng Index | 25.320 HKD | +0.320 | +1.280% | 482.27M | 12.17B | 24.992 (+1.312%) HKD as at 2025/07/17 | | |
| Hang Seng China Enterprises | 92.000 HKD | +1.240 | +1.366% | 103.96M | 9.52B | 90.630 (+1.512%) HKD as at 2025/07/17 | | |
| Hang Seng TECH Index | 5.440 HKD | +0.085 | +1.587% | 835.59M | 4.53B | 5.354 (+1.612%) HKD as at 2025/07/17 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.555 HKD | +0.190 | +3.541% | 218.62M | 1.21B | 5.385 (+3.157%) HKD as at 2025/07/17 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.570 HKD | -0.058 | -3.563% | 509.42M | 804.76M | 1.623 (-3.248%) HKD as at 2025/07/17 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.066 HKD | -0.056 | -2.639% | 153.74M | 319.23M | 2.131 (-3.046%) HKD as at 2025/07/17 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.630 HKD | +0.140 | +2.550% | 41.93M | 235.06M | 5.466 (+3.002%) HKD as at 2025/07/17 | | |
| Hang Seng TECH Index | 11.660 HKD | +0.200 | +1.745% | 18.19M | 211.56M | 11.412 (+2.170%) HKD as at 2025/07/16 | | |
| Hang Seng China Enterprises | 10.740 HKD | +0.050 | +0.468% | 10.80M | 115.84M | 10.648 (+0.862%) HKD as at 2025/07/16 | | |
| Hang Seng TECH Index | 5.525 HKD | +0.095 | +1.750% | 18.45M | 101.62M | 5.404 (+2.235%) HKD as at 2025/07/16 | | |
| CSI 300 | 46.360 HKD | +0.440 | +0.958% | 1.25M | 57.98M | 46.094 (+0.576%) HKD as at 2025/07/17 | | |
| FTSE China A50 | 14.770 HKD | +0.170 | +1.164% | 3.32M | 48.81M | 14.601 (+1.157%) HKD as at 2025/07/16 | | |
| SSE Science and Technology Innovation Board 50 Index | 9.205 HKD | -0.055 | -0.594% | 3.54M | 32.66M | 9.307 (-1.095%) HKD as at 2025/07/17 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 15.920 HKD | +0.170 | +1.079% | 1.84M | 29.13M | 15.742 (+1.130%) HKD as at 2025/07/17 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 8.690 HKD | +0.400 | +4.825% | 2.97M | 25.85M | 8.254 (+5.286%) HKD as at 2025/07/17 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.890 HKD | -0.052 | -1.319% | 6.06M | 23.57M | 3.957 (-1.696%) HKD as at 2025/07/16 | | |
| London Gold Fixing Price | 2,420.000 HKD | +15.000 | +0.624% | 8.73K | 21.08M | N/A | | |
| Hang Seng Index (net total return version) | 90.900 HKD | +1.100 | +1.225% | 231.39K | 20.97M | 89.894 (+1.120%) HKD as at 2025/07/16 | | |
| FTSE US Treasury 20+ Years Index | 66.880 HKD | +0.560 | +0.844% | 263.33K | 17.59M | 67.353 (-0.702%) HKD as at 2025/07/16 | | |
| CSI Hong Kong Dividend | 37.220 HKD | +0.360 | +0.977% | 446.80K | 16.58M | 36.845 (+1.018%) HKD as at 2025/07/17 | | |
| FTSE China A50 | 13.750 HKD | +0.150 | +1.103% | 1.17M | 15.99M | 13.634 (+0.852%) HKD as at 2025/07/17 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.780 HKD | +0.100 | +0.681% | 1.02M | 15.18M | 14.631 (+1.020%) HKD as at 2025/07/17 | | |
| CME Bitcoin Futures | 40.680 HKD | +0.320 | +0.793% | 347.50K | 14.24M | 40.654 (+0.064%) HKD as at 2025/07/16 | | |
| SSE Science and Technology Innovation Board 50 Index | 6.730 HKD | -0.005 | -0.074% | 2.00M | 13.41M | 6.756 (-0.383%) HKD as at 2025/07/17 | | |
| CME Ether Futures | 17.270 HKD | +0.750 | +4.540% | 775.40K | 13.38M | 16.164 (+6.844%) HKD as at 2025/07/16 | | |
| Hang Seng High Dividend Yield | 29.120 HKD | +0.200 | +0.692% | 453.80K | 13.19M | 28.956 (+0.565%) HKD as at 2025/07/16 | | |
| Hang Seng Index | 23.160 CNY | +0.280 | +1.224% | 546.00K | 12.64M | 22.876 (+1.240%) CNY as at 2025/07/17 | | |
| Solactive China Biotech Index NTR | 70.880 HKD | +0.580 | +0.825% | 171.33K | 12.13M | 67.464 (+5.063%) HKD as at 2025/07/16 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.510 HKD | +0.102 | +2.993% | 2.70M | 9.41M | 3.393 (+3.436%) HKD as at 2025/07/17 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng China Enterprises | 1.580 HKD | -0.050 | -3.067% | 4.31M | 6.87M | 1.636 (-3.405%) HKD as at 2025/07/17 | | |